Corporate Responsibility Report

The report describes GSK's 2013 progress in improving global health access, including a major milestone for its RTS,S malaria vaccine candidate and continued partnerships to expand healthcare delivery. It reports a 25% reduction target for the overall carbon footprint, alongside a 2013 Scope 1 and 2 figure of 1.83 million tonnes CO2e, lower operational water use and reduced waste versus the 2010 baseline. The report also details responsible-business governance, human-rights work and independent Bureau Veritas assurance of Environment, Health and Safety performance data.